Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45219 | 25625278 | PLoS Pathog | Implication of gut microbiota in nonalcoholic fatty liver disease. | 2015 | Details |
| A45220 | 25624707 | World J Gastroenterol | Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. | 2015 | Details |
| A45221 | 25620397 | J Hepatol | Epicardial fat and liver disease; the contribution of cardio autonomic nervous system function. | 2015 | Details |
| A45222 | 25619318 | Liver Int | Non-invasive evaluation of liver fibrosis: More well-validated tests available for patient management. | 2015 | Details |
| A45223 | 25618312 | Dig Dis Sci | Reversing Advanced Hepatic Fibrosis in NASH: Clearly Possible, but Widely at Hand? | 2015 | Details |
| A45224 | 25617498 | J Hepatol | Non-alcoholic fatty liver disease: severity of fibrosis and its relationships with clinical and biological variables. | 2015 | Details |
| A45225 | 25617496 | J Hepatol | Epicardial fat in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A45226 | 25613314 | Gastroenterology | Identifying molecular targets to improve immune function in alcoholic hepatitis. | 2015 | Details |
| A45227 | 25613312 | Gastroenterology | The changing liver transplant waitlist: an emerging liver purgatory? | 2015 | Details |
| A45228 | 25613311 | Gastroenterology | Inherited susceptibility to pancreatic cancer in the era of next-generation sequencing. | 2015 | Details |
| A45229 | 25602593 | J Hepatol | Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease? | 2015 | Details |
| A45230 | 25601464 | Curr Mol Med | Still water runs deep. | 2015 | Details |
| A45231 | 25600478 | Rev Recent Clin Trials | Non-alcoholic fatty liver disease: today and tomorrow. | 2014 | Details |
| A45232 | 25588104 | J Interferon Cytokine Res | Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon. | 2015 | Details |
| A45233 | 25587619 | J Gastroenterol Hepatol | Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease. | 2014 | Details |
| A45234 | 25578638 | World J Urol | Comment on "Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study". | 2015 | Details |
| A45235 | 25565897 | HIV AIDS (Auckl) | Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. | 2014 | Details |
| A45236 | 25564814 | J Pediatr Gastroenterol Nutr | Authors' response. | 2015 | Details |
| A45237 | 25564813 | J Pediatr Gastroenterol Nutr | Nonalcoholic fatty liver disease and dyslipidemia: the beleagured hepatocyte. | 2015 | Details |
| A45238 | 25564811 | J Pediatr Gastroenterol Nutr | Overstated associations between fructose and nonalcoholic fatty liver disease. | 2015 | Details |
| A45239 | 25564771 | Hepatology | Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis. | 2015 | Details |
| A45240 | 25564660 | Proc Natl Acad Sci U S A | Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. | 2015 | Details |
| A45241 | 25560844 | Nat Rev Gastroenterol Hepatol | NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD. | 2015 | Details |
| A45242 | 25560752 | Int Immunopharmacol | An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer. | 2015 | Details |
| A45243 | 25559329 | J Hepatol | Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. | 2015 | Details |
| A45244 | 25559327 | J Hepatol | HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. | 2015 | Details |
| A45245 | 25551207 | J Clin Gastroenterol | Evaluation of metabolic syndrome and nonalcoholic steatohepatitis. | 2015 | Details |
| A45246 | 25551206 | J Clin Gastroenterol | MRI, CT scan, and ultrasound in the diagnosis of nonalcoholic fatty liver disease. | 2015 | Details |
| A45247 | 25550401 | Circ Cardiovasc Imaging | Trimming the fat, do we know where to begin? | 2014 | Details |
| A45248 | 27508202 | J Hepatocell Carcinoma | Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. | 2015 | Details |
| A45249 | 27228156 | Nat Rev Dis Primers | Nonalcoholic fatty liver disease. | 2015 | Details |
| A45250 | 25548259 | J Lipid Res | ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content. | 2014 | Details |
| A45251 | 25547844 | Expert Opin Investig Drugs | Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. | 2014 | Details |
| A45252 | 25546414 | Hepatology | Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A45253 | 25544406 | Rev Esp Enferm Dig | Obesity-related non-alcoholic fatty liver disease (NAFLD): A multifactorial process. | 2014 | Details |
| A45254 | 25543233 | J Gastroenterol | Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. | 2014 | Details |
| A45255 | 25523490 | J Hepatol | From the editor's desk ... | 2015 | Details |
| A45256 | 25514904 | J Lipid Res | KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression. | 2014 | Details |
| A45257 | 25502834 | Hepatology | TM6SF2 as a genetic risk factor for fibrosis. | 2015 | Details |
| A45258 | 25502625 | Hepatology | Reply: To PMID 25302781. | 2015 | Details |
| A45259 | 25501880 | Curr Opin Lipidol | Dietary patterns and fatty liver disease. | 2015 | Details |
| A45260 | 25501544 | Am J Physiol Gastrointest Liver Physiol | A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice. | 2014 | Details |
| A45261 | 25489472 | Ther Adv Endocrinol Metab | Vitamin D insufficiency and insulin resistance in obese adolescents. | 2014 | Details |
| A45262 | 25483735 | J Surg Res | BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury. | 2014 | Details |
| A45263 | 25483431 | Aliment Pharmacol Ther | Editorial: would an aspirin a day keep NAFLD and its complications away? | 2015 | Details |
| A45264 | 25482317 | Hepatology | PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease. | 2015 | Details |
| A45265 | 25482212 | Hepatology | Reply: To PMID 25251399. | 2015 | Details |
| A45266 | 25478921 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease and fibrosis progression: the good, the bad, and the unknown. | 2014 | Details |
| A45267 | 25476673 | Magn Reson Imaging Clin N Am | MR of multi-organ involvement in the metabolic syndrome. | 2015 | Details |
| A45268 | 25469457 | Liver Int | Response to Importance of confounding factors in assessing fatty acid compositions in patients with non-alcoholic steatohepatitis. | 2015 | Details |
| A45269 | 25469034 | World J Gastroenterol | Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? | 2014 | Details |
| A45270 | 25468251 | Eur J Intern Med | Proper cut-off points to distinguish patients with NASH from non-NASH. | 2014 | Details |
| A45271 | 25468161 | Lancet | Starting the battle to control non-alcoholic steatohepatitis. | 2014 | Details |
| A45272 | 25465468 | Redox Biol | Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. | 2014 | Details |
| A45273 | 25455415 | J Diabetes Complications | A biochemical view: Increase in polyunsaturated fatty acid ω-6/ω-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A45274 | 25454303 | Clin Liver Dis | Liver disease in the adolescent. | 2014 | Details |
| A45275 | 25450705 | J Hepatol | NAFLD incidence and remission: only a matter of weight gain and weight loss? | 2014 | Details |
| A45276 | 25437347 | Scand J Gastroenterol | Some important points for the selection and exclusion of patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A45277 | 25436233 | ScientificWorldJournal | Is there a role for probiotics in liver disease? | 2014 | Details |
| A45278 | 25422106 | Diabetes | Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance. | 2014 | Details |
| A45279 | 25421586 | Nat Rev Gastroenterol Hepatol | NAFLD: obeticholic acid for the treatment of fatty liver disease--NASH no more? | 2014 | Details |
| A45280 | 25418405 | World Rev Nutr Diet | Liver diseases. | 2014 | Details |
| A45281 | 25410004 | Liver Int | Importance of confounding factors in assessing fatty acid compositions in patients with non-alcoholic steatohepatitis. | 2015 | Details |
| A45282 | 25400456 | World J Gastroenterol | GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells. | 2014 | Details |
| A45283 | 25385228 | Nat Rev Gastroenterol Hepatol | NAFLD: Ketogenesis could be a determinant of steatohepatitis. | 2014 | Details |
| A45284 | 25381672 | Turk J Gastroenterol | Author's reply: To PMID 25003670. | 2014 | Details |
| A45285 | 25381603 | Endocrine | Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A45286 | 25381142 | Angiology | Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation. | 2014 | Details |
| A45287 | 25373858 | J Pediatr Gastroenterol Nutr | On the origin of pediatric nonalcoholic Fatty liver disease. | 2015 | Details |
| A45288 | 25372290 | PLoS One | Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis. | 2014 | Details |
| A45289 | 25371483 | Gastroenterol Rep (Oxf) | The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease. | 2014 | Details |
| A45290 | 25371482 | Gastroenterol Rep (Oxf) | Commentary on "Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease". | 2014 | Details |
| A45291 | 25371481 | Gastroenterol Rep (Oxf) | Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease? | 2014 | Details |
| A45292 | 25358204 | J Ayub Med Coll Abbottabad | Fatty liver: yet another silent killer. | 2014 | Details |
| A45293 | 25357150 | J Med Food | Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets. | 2014 | Details |
| A45294 | 25350520 | Horm Metab Res | Nonalcoholic Fatty liver disease and hyperuricemia: a close relation with hepatic insulin resistance after nicotinic Acid treatment? | 2014 | Details |
| A45295 | 25342734 | Diabetes | Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. | 2014 | Details |
| A45296 | 25308328 | Hepatology | Nitric oxide as a protector from nonalcoholic fatty liver disease. | 2015 | Details |
| A45297 | 25308174 | J Hepatol | Deficiency of periostin protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis. | 2014 | Details |
| A45298 | 25304010 | Wien Klin Wochenschr | Screening of nonalcoholic fatty liver disease in patients with coronary heart disease by transient elastography: proceed with caution. | 2014 | Details |
| A45299 | 25295785 | Cell Metab | Periostin: a new extracellular regulator of obesity-induced hepatosteatosis. | 2014 | Details |
| A45300 | 25293340 | Curr Treat Options Cardiovasc Med | Childhood obesity and insulin resistance: how should it be managed? | 2014 | Details |
| A45301 | 25287814 | J Nutr Biochem | High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids. | 2014 | Details |
| A45302 | 25286440 | Gastroenterology | Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury. | 2014 | Details |
| A45303 | 25282737 | Zhonghua Gan Zang Bing Za Zhi | [Roles of microRNAs in non-alcoholic fatty liver disease]. | 2014 | Details |
| A45304 | 25278702 | World J Gastroenterol | Role of Nrf2 in chronic liver disease. | 2014 | Details |
| A45305 | 25259866 | Child Obes | Ducks, geese, faith, and fatty livers. | 2014 | Details |
| A45306 | 25254546 | Turk J Gastroenterol | Antioxidant treatment in nonalcoholic fatty liver disease. | 2014 | Details |
| A45307 | 25253983 | World J Gastroenterol | Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? | 2014 | Details |
| A45308 | 25241133 | Dig Liver Dis | Weight loss outcomes after liver biopsy in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A45309 | 25240528 | Acta Diabetol | Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes. | 2014 | Details |
| A45310 | 25239614 | BMJ | Non-alcoholic fatty liver disease. | 2014 | Details |
| A45311 | 25239591 | Gastroenterology | Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. | 2014 | Details |
| A45312 | 25230688 | Mol Med Rep | Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy. | 2014 | Details |
| A45313 | 25222975 | Zhonghua Gan Zang Bing Za Zhi | [Fructose as a risk factor nonalcoholic fatty liver disease]. | 2014 | Details |
| A45314 | 25222974 | Zhonghua Gan Zang Bing Za Zhi | [Clinical correlates of histopathology in non-obese non-alcoholic fatty liver disease]. | 2014 | Details |
| A45315 | 25209117 | Hepatology | GLI2 as a marker of hedgehog-responsive cells. | 2015 | Details |
| A45316 | 25209009 | Hepatology | Reply: To PMID 24849310. | 2015 | Details |
| A45317 | 25205081 | Gastroenterol Hepatol | [Acute liver injury induced by green tea extracts]. | 2014 | Details |
| A45318 | 25203153 | J Investig Med | Age and ethnicity in cirrhosis. | 2014 | Details |